Rchr
J-GLOBAL ID：201701005701140888   Update date: Jun. 24, 2024

Morita Ken

Morita Ken
Affiliation and department：
Dana-Farber Cancer Institute, Harvard Medical School Pediatric Oncology Department

About Dana-Farber Cancer Institute, Harvard Medical School Pediatric Oncology Department


Job title： Resaerch Fellow
Research field  (1)： Tumor biology
Research keywords  (3)： Cancer Biology ,  Cellular Biology ,  Hematology & Oncology
Research theme for competitive and other funds  (11)：
  • 2020 - 2021 Overseas Research Fellowship
  • 2020 - 2021 WES Research Grant
  • 2020 - 2021 Innovative Pediatric Cancer Research Award
  • 2018 - 2020 Overseas Research Fellowships
  • 2016 - 2018 Deciphering the function of KLF4 in myeloid dysplastic syndrome (MDS).
Show all
Papers (23)：
  • Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno, Mari Sonoda, Keiji Tasaka, Hideto Ogata, Kagehiro Kouzuki, Seishiro Nodomi, Satoshi Saida, Itaru Kato, et al. CD146 is a potential immunotarget for neuroblastoma. Cancer science. 2021. 112. 11. 4617-4626
  • Mina Noura, Ken Morita, Hiroki Kiyose, Yukiko Okuno, Hidemasa Matsuo, Asami Koyama, Yoko Nishinaka-Arai, Yasuhiko Kamikubo, Souichi Adachi. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis. British journal of haematology. 2021. 194. 3. 598-603
  • Hiroaki Maki, Akihide Yoshimi, Takashi Shimada, Shunya Arai, Ken Morita, Yasuhiko Kamikubo, Masaya Ikegawa, Mineo Kurokawa. Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia. Experimental hematology. 2021. 94. 31-36
  • Mina Noura, Ken Morita, Hiroki Kiyose, Hidemasa Matsuo, Yoko Nishinaka-Arai, Mineo Kurokawa, Yasuhiko Kamikubo, Souichi Adachi. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells. Scientific Reports. 2020. 10. 1. 20245-20245
  • Tomoo Daifu, Masamitsu Mikami, Hidefumi Hiramatsu, Atsushi Iwai, Katsutsugu Umeda, Mina Noura, Hirohito Kubota, Tatsuya Masuda, Kana Furuichi, Saho Takasaki, et al. Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition. Pediatric Blood & Cancer. 2020. 68. 2. e28789
ｍore...
MISC (10)：
ｍore...
Professional career (2)：
  • M.D. (The University of Tokyo, Tokyo, Japan)
  • Ph.D. (The University of Tokyo, Tokyo, Japan)
Work history (8)：
  • 2017/07 - 現在 Dana-Farber Cancer Institute, Harvard Medical School Pediatric Oncology Department Research Fellow
  • 2018/04 - 2020/03 Overseas Research Fellowships, Japan Society for the Promotion of Science (JSPS)
  • 2015/04 - 2017/06 Kyoto University, Kyoto, Japan. Graduate School of Medicine Research Fellow
  • 2016/04 - 2017/03 The Institute of Medical Science, The University of Tokyo Program-specific Research fellow
  • 2013/04 - 2015/03 Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists
Show all
Awards (10)：
  • 2021 - NIH/NCI (USA) K99/R00 Pathway to Independence Award
  • 2019/12 - American Society of Hematology ASH Abstract Achievement Award
  • 2018 - Japanese Cancer Association Incitement Award of the Japanese Cancer Association
  • 2018 - Thrasher Research Fund Early Career Award
  • 2017 - European Hematology Association (EHA)/ Japanese Society of Hematology (JSH) EHA Travel Award
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM